Gene-environment interaction and Mendelian randomisation.

Published on Sep 19, 2019in Revue Neurologique2.177
· DOI :10.1016/J.NEUROL.2019.04.010
Pierre Kolber3
Estimated H-index: 3
(Centre Hospitalier de Luxembourg),
P. Kolber (Centre Hospitalier de Luxembourg)+ -1 AuthorsR. Krüger (Centre Hospitalier de Luxembourg)
Abstract Genetic factors only account for up to a third of the cases of Parkinson's disease (PD), while the remaining cases are of unknown aetiology. Environmental exposures (such as pesticides or heavy metals) and the interaction with genetic susceptibility factors (summarized in the concept of impaired xenobiotic metabolism) are believed to play a major role in the mechanisms of neurodegeneration. Beside of the classical association studies (e.g. genome-wide association studies), a novel approach to investigate environmental risk factors are Mendelian randomisation studies. This review explores the gene-environment interaction and the gain of Mendelian randomisation studies in assessing causalities of modifiable risk factors for PD.
  • References (82)
  • Citations (1)
📖 Papers frequently viewed together
18 Authors (Rebecca C. Richmond, ..., Kurt Straif)
17 Authors (David R. Blair, ..., Andrey Rzhetsky)
141 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
#1Alex J. Cornish (ICR: Institute of Cancer Research)H-Index: 7
#2Ian Tomlinson (University of Birmingham)H-Index: 102
Last. Richard S. Houlston (ICR: Institute of Cancer Research)H-Index: 95
view all 3 authors...
Colorectal cancer (CRC) is the third most common cancer in economically developed countries and a major cause of cancer-related mortality. The importance of lifestyle and diet as major determinants of CRC risk is suggested by differences in CRC incidence between countries and in migration studies. Previous observational epidemiological studies have identified associations between modifiable environmental risk factors and CRC, but these studies can be susceptible to reverse causation and confound...
3 CitationsSource
#1Geraldine Hipp (Centre Hospitalier de Luxembourg)H-Index: 2
#2Michel VaillantH-Index: 24
Last. Rejko Krüger (Centre Hospitalier de Luxembourg)H-Index: 45
view all 26 authors...
While genetic advances have successfully defined part of the complexity in Parkinson’s disease (PD), the clinical characterization of phenotypes remains challenging. Therapeutic trials and cohort studies typically include patients with earlier disease stages and exclude comorbidities, thus ignoring a substantial part of the real-world PD population. To account for these limitations, we implemented the Luxembourg PD study as a comprehensive clinical, molecular and device-based approach including ...
8 CitationsSource
#1Loic Yengo (UQ: University of Queensland)H-Index: 47
#2Julia Sidorenko (UT: University of Tartu)H-Index: 11
Last. Peter M. Visscher (UQ: University of Queensland)H-Index: 112
view all 10 authors...
Recent genome-wide association studies (GWAS) of height and body mass index (BMI) in ∼250000 European participants have led to the discovery of ∼700 and ∼100 nearly independent single nucleotide polymorphisms (SNPs) associated with these traits, respectively. Here we combine summary statistics from those two studies with GWAS of height and BMI performed in ∼450000 UK Biobank participants of European ancestry. Overall, our combined GWAS meta-analysis reaches N ∼700000 individuals and substantiall...
141 CitationsSource
#1Marilyn C. Cornelis (NU: Northwestern University)H-Index: 50
#2Marcus R. MunafòH-Index: 72
Habitual coffee and caffeine consumption has been reported to be associated with numerous health outcomes. This perspective focuses on Mendelian Randomization (MR) approaches for determining whether such associations are causal. Genetic instruments for coffee and caffeine consumption are described, along with key concepts of MR and particular challenges when applying this approach to studies of coffee and caffeine. To date, at least fifteen MR studies have investigated the causal role of coffee ...
8 CitationsSource
#1Camilla J. Kobylecki (Copenhagen University Hospital)H-Index: 8
#2Børge G. Nordestgaard (UCPH: University of Copenhagen)H-Index: 125
Last. Shoaib Afzal (Copenhagen University Hospital)H-Index: 26
view all 3 authors...
OBJECTIVE: Urate is a potent antioxidant, and high plasma urate has been associated with lower incidence of Parkinson's disease (PD) in epidemiological studies. We tested the hypothesis that high concentrations of plasma urate are associated with low incidence of PD. METHODS: We performed observational and genetic analyses using plasma urate and the urate SLC2A9 rs7442295 and ABCG2 rs2231142 genotype in >102,000 individuals from the CGPS (Copenhagen General Population Study). Information on PD a...
7 CitationsSource
#1Demis A. Kia (UCL Institute of Neurology)H-Index: 7
#2Alastair J. Noyce (UCL Institute of Neurology)H-Index: 22
Last. Nicholas W. Wood (UCL: University College London)H-Index: 106
view all 12 authors...
DAK is supported by an MB PhD Award from the International Journal of Experimental Pathology. AJN is funded by Parkinson’s UK (ref G1606) and the Barts Charity (Preventive Neurology Unit). GDS and DAL work in a unit that receives funding from the University of Bristol and the UK Medical Research Council (MC_UU_1201/1 and MC_UU_1201/5). DAL is a National Institute of Health Research Senior Investigator (NF-SI-0166-10196). MN, AS and AN participation in this study was supported in part by the Intr...
4 CitationsSource
#1S. B. Larsen (University of Luxembourg)H-Index: 1
#2Zoé Hanss (University of Luxembourg)H-Index: 1
Last. Rejko Krüger (Centre Hospitalier de Luxembourg)H-Index: 45
view all 3 authors...
Mitochondrial impairment is a well-established pathological pathway implicated in Parkinson’s disease (PD). Defects of the complex I of the mitochondrial respiratory chain have been found in post-mortem brains from sporadic PD patients. Furthermore, several disease-related genes are linked to mitochondrial pathways, such as PRKN, PINK1, DJ-1 and HTRA2 and are associated with mitochondrial impairment. This phenotype can be caused by the dysfunction of mitochondrial quality control machinery at di...
30 CitationsSource
#1Geir BjørklundH-Index: 23
#2Vera Stejskal (Stockholm University)H-Index: 6
Last. Joachim MutterH-Index: 4
view all 6 authors...
Genetic background accounts for only 5 to 10% of the reported cases of Parkinson's disease (PD), while the remaining cases are of unknown etiology. It is believed that environmental factors may be ...
15 CitationsSource
#1Tim Vlaar (Université Paris-Saclay)H-Index: 2
#2Sofiane Kab (Université Paris-Saclay)H-Index: 6
Last. Frédéric MoisanH-Index: 11
view all 6 authors...
In order to identify working environments at risk for Parkinson’s disease (PD), we investigated the relation between the importance of industry sectors, used as a surrogate for occupational exposures, and PD incidence in French cantons. The number of incident PD cases (2010–2014) in 3689 cantons of metropolitan France was determined using drug claims from French National Health Insurance databases. The proportions of workers in 38 industry sectors in 2006 were calculated for each canton. Associa...
6 CitationsSource
#1Ehsan Shokri-Kojori (NIH: National Institutes of Health)H-Index: 13
#2Gene-Jack Wang (NIH: National Institutes of Health)H-Index: 25
Last. Nora D. Volkow (NIH: National Institutes of Health)H-Index: 143
view all 17 authors...
The effects of acute sleep deprivation on β-amyloid (Aβ) clearance in the human brain have not been documented. Here we used PET and 18 F-florbetaben to measure brain Aβ burden (ABB) in 20 healthy controls tested after a night of rested sleep (baseline) and after a night of sleep deprivation. We show that one night of sleep deprivation, relative to baseline, resulted in a significant increase in Aβ burden in the right hippocampus and thalamus. These increases were associated with mood worsening ...
67 CitationsSource
Cited By1
#1Jochen Ohnmacht (University of Luxembourg)H-Index: 3
#2Patrick May (University of Luxembourg)H-Index: 30
Last. Rejko Krüger (Centre Hospitalier de Luxembourg)H-Index: 45
view all 4 authors...
Parkinson's disease (PD) is a neurodegenerative disorder caused by a complex interplay of genetic and environmental factors. For the stratification of PD patients and the development of advanced clinical trials, including causative treatments, a better understanding of the underlying genetic architecture of PD is required. Despite substantial efforts, genome-wide association studies have not been able to explain most of the observed heritability. The majority of PD-associated genetic variants ar...
1 CitationsSource